how does glutathione s-transferase cause drug resistance in cancer cells Unveiling the Role of Protein Breast Resistance: Insights into the Signaling Pathways and Therapeutic Implications Glutathione S-transferase π: a potential

This collaboration led to the development of SHIRATAMA BOOSTER, a dietary supplement that simplifies the intake of glutathione

demonstrated in patients with advanced colorectal cancer treated by either anti-EGFR inhibition or without, the expression of autophagy proteins Beclin-1 and LC3 were not only associated with advanced colorectal cancer, but those with higher expression of these proteins experienced worse objective response rates, and shorter progression free survival

We recently discovered that many human plasma proteins are also specifically converted into chaperone-like holdases by N-chlorination and as such, gain the ability to protect other proteins from HOCl-induced aggregation [37]

Ferroptosis, characterized by GPX4 inhibition and iron-dependent lipid peroxidation, occurs in iron-rich cells such as glioblastomas and neurons, and is often triggered by decreased SLC7A11 expression or cystine depletion